120 filings
8-K
HGSI
Human Genome Sciences
8 Aug 12
Completion of Acquisition or Disposition of Assets
12:00am
8-K
HGSI
Human Genome Sciences
1 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
HGSI
Human Genome Sciences
16 Jul 12
GSK to acquire Human Genome Sciences for US$14.25 per share in cash
12:00am
8-K
HGSI
Human Genome Sciences
17 May 12
Human Genome Sciences Announces Adoption of
12:00am
8-K
HGSI
Human Genome Sciences
16 May 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ku1u z3qi9zqdh
24 Apr 12
Results of Operations and Financial Condition
12:00am
8-K
ocig3mtklyoyg
19 Apr 12
Human Genome Sciences Announces Unsolicited Offer from Glaxosmithkline; HGS Board of Directors Authorizes Exploration of Strategic Alternatives
12:00am
8-K
kzi4lzca6 7v9z8ugfy
27 Feb 12
Results of Operations and Financial Condition
12:00am
8-K
b4q4 7btm2tufsr
9 Jan 12
Human Genome Sciences Reports Progress with Commercialization of Benlysta® and Announces 2012 Goals at Jpmorgan Healthcare Conference
12:00am
8-K
6yp50qubv oycb94
16 Nov 11
GSK receives initial data from the first completed phase III study of albiglutide in type 2 diabetes
12:00am
8-K
gnz 8kqbuwxs6m6r
10 Nov 11
Regulation FD Disclosure
12:00am
8-K
car aoxlo5biucx9wwv
7 Nov 11
Entry into a Material Definitive Agreement
12:00am
8-K
z84rl
25 Oct 11
Human Genome Sciences Announces Third Quarter 2011 Financial Results and Key Developments
12:00am
8-K
rn0308yp
30 Sep 11
NICE draft guidance denies funding for lupus treatment Benlysta on the NHS
12:00am
8-K
ij5dd5edx9 iae2n3
8 Sep 11
Regulation FD Disclosure
12:00am
8-K
u9bufapnzpmnnenb6o8
1 Aug 11
Unregistered Sales of Equity Securities
12:00am
8-K
o0cixl 9w
21 Jul 11
Human Genome Sciences Announces Second Quarter 2011 Financial Results and Key Developments
12:00am
8-K
m1p8dbn0lt817o17m9
14 Jul 11
Other Events
12:00am
8-K/A
jvdjivlm5kv0 zsgs
12 May 11
Departure of Directors or Certain Officers
12:00am
8-K
h4w7wrbl
28 Apr 11
Human Genome Sciences Announces First Quarter 2011 Financial Results and Key Developments
12:00am